Aims: To evaluate the impact of lockdown during the COVID-19 pandemic on lifestyle changes of the general population, and on admissions for acute coronary syndrome (ACS). Methods and Results: All ACS admissions during the COVID-19 lockdown (10 March to 4 May, 2020), in 3 municipalities (3 spoke, and 1 hub hospital), in Southwestern Greece (411,576 inhabitants), were prospectively recorded and compared to the equivalent periods during 2018, and 2019. A telephone survey of 1014 participants was conducted to explore the lifestyle habits of citizens aged ≥35-years-old before and during lockdown. The median ACS incidence rate decreased from 19.0 cases per week in 2018 and 21.5 in 2019 down to 13.0 in 2020 (RR: 0.66 during the Covid-19 lockdown; 95%CI: 0.53-0.82; P = 0.0002). This was driven by a significant reduction of admissions for Non-ST elevation myocardial infarction (NSTEMI) (RR: 0.68; 95%CI: 0.52-0.88; P = 0.0037), mainly in patients with a lower burden of cardiovascular risk factors, as we noticed an inverse association between the reduction of the incidence of ACS during the Covid-19 lockdown period and the number of registered patient risk factors. There was no difference in the rates of STEMI and population-based all-cause mortality across the examined time periods. The telephone survey demonstrated reduction of passive smoking, working hours, alcohol, junk food and salt consumption, and an increase in sleeping hours, mainly in participants with a lower burden of cardiovascular risk factors. Conclusions: A significant decline in ACS admissions during the COVID-19 lockdown was noted, affecting mainly NSTEMI patients with a lower burden of cardiovascular risk factors. This was accompanied by significant lifestyle changes. Thus, it is tempting to speculate that to some extend the latter might be associated with the observed decline in ACS admissions.
Aims: To evaluate the impact of lockdown during the COVID-19 pandemic on lifestyle changes of the general population, and on admissions for acute coronary syndrome (ACS). Methods and Results: All ACS admissions during the COVID-19 lockdown (10 March to 4 May, 2020), in 3 municipalities (3 spoke, and 1 hub hospital), in Southwestern Greece (411,576 inhabitants), were prospectively recorded and compared to the equivalent periods during 2018, and 2019. A telephone survey of 1014 participants was conducted to explore the lifestyle habits of citizens aged ≥35-years-old before and during lockdown. The median ACS incidence rate decreased from 19.0 cases per week in 2018 and 21.5 in 2019 down to 13.0 in 2020 (RR: 0.66 during the Covid-19 lockdown; 95%CI: 0.53-0.82; P = 0.0002). This was driven by a significant reduction of admissions for Non-ST elevation myocardial infarction (NSTEMI) (RR: 0.68; 95%CI: 0.52-0.88; P = 0.0037), mainly in patients with a lower burden of cardiovascular risk factors, as we noticed an inverse association between the reduction of the incidence of ACS during the Covid-19 lockdown period and the number of registered patient risk factors. There was no difference in the rates of STEMI and population-based all-cause mortality across the examined time periods. The telephone survey demonstrated reduction of passive smoking, working hours, alcohol, junk food and salt consumption, and an increase in sleeping hours, mainly in participants with a lower burden of cardiovascular risk factors. Conclusions: A significant decline in ACS admissions during the COVID-19 lockdown was noted, affecting mainly NSTEMIpatients with a lower burden of cardiovascular risk factors. This was accompanied by significant lifestyle changes. Thus, it is tempting to speculate that to some extend the latter might be associated with the observed decline in ACS admissions.
Authors: Thorsten Kälsch; Elif Elmas; Xuan Duc Nguyen; Hans Leweling; Harald Klüter; Martin Borggrefe; Carl Erik Dempfle Journal: Int J Cardiol Date: 2007-03-21 Impact factor: 4.164
Authors: Chor-Cheung Frankie Tam; Kent-Shek Cheung; Simon Lam; Anthony Wong; Arthur Yung; Michael Sze; Yui-Ming Lam; Carmen Chan; Tat-Chi Tsang; Matthew Tsui; Hung-Fat Tse; Chung-Wah Siu Journal: Circ Cardiovasc Qual Outcomes Date: 2020-03-17
Authors: Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry Journal: J Am Coll Cardiol Date: 2020-04-10 Impact factor: 24.094
Authors: Holger M Nef; Albrecht Elsässer; Helge Möllmann; Mohammed Abdel-Hadi; Timm Bauer; Martin Brück; Holger Eggebrecht; Joachim R Ehrlich; Markus W Ferrari; Stephan Fichtlscherer; Ulrich Hink; Hans Hölschermann; Rifat Kacapor; Oliver Koeth; Serguei Korboukov; Steffen Lamparter; Alexander J Laspoulas; Ralf Lehmann; Christoph Liebetrau; Tobias Plücker; Jörn Pons-Kühnemann; Volker Schächinger; Bernhard Schieffer; Peter Schott; Matthias Schulze; Claudius Teupe; Mariuca Vasa-Nicotera; Michael Weber; Christoph Weinbrenner; Gerald Werner; Christian W Hamm; Oliver Dörr Journal: Clin Res Cardiol Date: 2020-11-21 Impact factor: 5.460
Authors: Claudia Álvarez-Martín; Aida Ribera; Josep Ramon Marsal; Albert Ariza-Solé; Santiago Pérez-Hoyos; Gerard Oristrell; Toni Soriano-Colomé; Rafael Romaguera; Jose Ignacio Pijoan; Rosa M Lidón; Josepa Mauri; Ignacio Ferreira-González Journal: Front Cardiovasc Med Date: 2022-04-26
Authors: Uwe Zeymer; Vusal Ahmadli; Steffen Schneider; Karl Werdan; Michael Weber; Sven Hohenstein; Gerhard Hindricks; Steffen Desch; Andreas Bollmann; Holger Thiele Journal: Clin Res Cardiol Date: 2022-08-17 Impact factor: 6.138